This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rittenhouse, B. E. Search for Related Content PubMed PubMed Citation Articles by Rittenhouse, B. E. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                   What's this?

The Relevance of Searching for Effects under a Clinical-trial Lamppost

A Key Issue

In economic evaluations of new medical technologies, analysts often need to use data from randomized controlled trials. Trials are designed to achieve high internal validity; however, their selected populations and often highly artificial environments may imply low external validity. Thus, the use of trial data in an economic evaluation may bias the results, since economic evaluation is concerned not with theoretical capability in a trial but with likely performance in the practice environment. This paper indicates both the probable bias of one aspect of artificiality in the trial environment—selected populations—and a method of ad justing the analysis so that results will be more likely to reflect actual practice. The judicious use of extra-trial information can be used to correct the biases of clinical trials. Key words: efficacy; effectiveness; clinical trials; diagnosis; external validity; bias; sepsis; bacteremia. (Med Decis Making 1995;15:348-357)

Medical Decision Making, Vol. 15, No. 4, 348-357 (1995)
DOI: 10.1177/0272989X9501500405


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. D. Reed, P. W. Dillingham, A. H. Briggs, D. L. Veenstra, and S. D. Sullivan A Bayesian Approach to Aid in Formulary Decision Making: Incorporating Institution-Specific Cost-Effectiveness Data with Clinical Trial Results Med Decis Making, May 1, 2003; 23(3): 252 - 264. [Abstract] [PDF]

				B. E. Rittenhouse Exorcising Protocol-induced Spirits:: Making the Clinical Trial Relevant for Economics Med Decis Making, July 1, 1997; 17(3): 331 - 339. [Abstract] [PDF]